Hsiang‐Ju Lin

Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial

Ching‐Lung Lai, Anna Suk‐Fong Lok, Pui–Chee Wu et al. · Cancer · 1988 · 361 citations · Full text

Surgical Oncology, Adria Laboratories, Pathology +18

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

Ching‐Lung Lai, Johnson Y. N. Lau, Pui–Chee Wu et al. · Hepatology · 1993 · 222 citations · Full text

PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN

Ching‐Lung Lai, Hsiang‐Ju Lin, Eng‐Kiong Yeoh et al. · The Lancet · 1987 · 171 citations

Immunodeficiencies, Immunology, Antiviral Therapy +3

Hepatitis C virus infection in kidney transplant recipients

Johnson Y.N. Lau, Gary L. Davis, Mathew E. Brunson et al. · Hepatology · 1993 · 98 citations

Second-generation Enzyme, Transplantation, Hepatology +12

Inhibition of nuclear factor κB is associated with neuroprotective effects of glycyrrhizic acid on glutamate-induced excitotoxicity in primary neurons

Jaw‐Ming Cherng, Hsiang‐Ju Lin, Man-Shan Hung et al. · European Journal of Pharmacology · 2006 · 80 citations

Nuclear Factor κB, Synaptic Signaling, Neurophysiology +13